Oprah departs WeightWatchers board after nearly 10 years as company struggles amid rising competition
-
Oprah Winfrey is departing WeightWatchers' board after nearly a decade, as the company faces declining profits and support. She intends to remain a vocal advocate for health equity.
-
Winfrey's departure caused WeightWatchers' stock to plunge 25%. The company faces rising competition from medications like Ozempic.
-
Winfrey plans to donate her WW stake and any future stock options to the National Museum of African American History and Culture.
-
WeightWatchers recently began embracing weight loss medications like Wegovy, a major shift from its traditional behavior-based approach.
-
The CEO acknowledged the company previously gave members detrimental advice by framing weight as a "choice," failing to account for chronic biological factors.